Form 4: Biodesix Executive Converts Preferred Stock to Common Stock

Chris Vazquez, Chief Accounting Officer of Biodesix Inc., converted Series A Non-Voting Convertible Preferred Stock into Common Stock on May 23, 2024, following stockholder approval.

Summary

• Chris Vazquez, the Chief Accounting Officer of Biodesix Inc., converted shares of Series A Non-Voting Convertible Preferred Stock into Common Stock.
• The conversion occurred on May 23, 2024.
• The conversion was triggered by stockholder approval at the company's annual meeting on May 21, 2024.
• Each share of Preferred Stock was converted into 40 shares of Common Stock.
• Vazquez converted 22 shares of Preferred Stock into 880 shares of Common Stock.
• Following the transaction, Vazquez directly owns 10,795 shares of Common Stock.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to a pre-planned conversion of stock, so it doesn't significantly impact sentiment.

Industry Context

Form 4 filings are a routine part of the US equity market and are required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The conversion of preferred stock to common stock may slightly dilute existing common shareholders' equity.

Key Dates